Robert Dworkin
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Neuralgia | 35 | 1994 | 13 |
Why?
| Herpes Zoster | 33 | 1992 | 17 |
Why?
| Pain | 47 | 1986 | 191 |
Why?
| Pain Measurement | 42 | 1992 | 98 |
Why?
| Analgesics | 19 | 2003 | 47 |
Why?
| Clinical Trials as Topic | 28 | 1984 | 251 |
Why?
| Neuralgia, Postherpetic | 12 | 2005 | 8 |
Why?
| Peripheral Nervous System Diseases | 12 | 2002 | 45 |
Why?
| Antiviral Agents | 15 | 1996 | 91 |
Why?
| Diabetic Neuropathies | 10 | 2003 | 16 |
Why?
| Lidocaine | 11 | 2000 | 49 |
Why?
| Pain, Intractable | 7 | 2005 | 9 |
Why?
| Evidence-Based Medicine | 9 | 2007 | 125 |
Why?
| gamma-Aminobutyric Acid | 9 | 2003 | 58 |
Why?
| Pain Management | 11 | 1985 | 32 |
Why?
| Chronic Disease | 30 | 1985 | 267 |
Why?
| Anesthetics, Local | 11 | 2000 | 50 |
Why?
| Research Design | 9 | 1997 | 169 |
Why?
| Humans | 118 | 1984 | 1856 |
Why?
| Pain, Postoperative | 4 | 2003 | 42 |
Why?
| Polyneuropathies | 5 | 2005 | 14 |
Why?
| Treatment Outcome | 24 | 1999 | 661 |
Why?
| Low Back Pain | 5 | 2005 | 25 |
Why?
| Cyclohexanecarboxylic Acids | 5 | 2003 | 24 |
Why?
| Amines | 5 | 2003 | 39 |
Why?
| Antidepressive Agents | 3 | 2005 | 46 |
Why?
| 2-Aminopurine | 5 | 1998 | 4 |
Why?
| Outcome Assessment (Health Care) | 8 | 2005 | 163 |
Why?
| Schizophrenic Psychology | 8 | 1988 | 18 |
Why?
| Public-Private Sector Partnerships | 2 | 2011 | 3 |
Why?
| Quality of Life | 10 | 2003 | 188 |
Why?
| Middle Aged | 41 | 1985 | 1161 |
Why?
| Randomized Controlled Trials as Topic | 11 | 1996 | 176 |
Why?
| Multiple Sclerosis | 4 | 1984 | 43 |
Why?
| Desipramine | 2 | 2009 | 20 |
Why?
| Schizophrenia | 7 | 1988 | 48 |
Why?
| Health Care Costs | 3 | 2007 | 73 |
Why?
| Female | 48 | 1984 | 1643 |
Why?
| Breast Neoplasms | 4 | 2003 | 185 |
Why?
| Health Planning Guidelines | 3 | 2003 | 19 |
Why?
| Severity of Illness Index | 9 | 2002 | 358 |
Why?
| Aged | 24 | 1992 | 988 |
Why?
| Skin | 3 | 2005 | 177 |
Why?
| Sickness Impact Profile | 2 | 2004 | 26 |
Why?
| Placebo Effect | 4 | 2005 | 26 |
Why?
| Adult | 32 | 1985 | 1317 |
Why?
| Male | 38 | 1984 | 1553 |
Why?
| Risk Factors | 17 | 1988 | 555 |
Why?
| Mastectomy | 2 | 2003 | 26 |
Why?
| Acute Disease | 9 | 1998 | 271 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2009 | 78 |
Why?
| Practice Guidelines as Topic | 4 | 2006 | 174 |
Why?
| Pain Threshold | 5 | 1994 | 11 |
Why?
| Analgesics, Opioid | 7 | 2003 | 37 |
Why?
| Osteoarthritis | 4 | 2005 | 51 |
Why?
| Risk Assessment | 3 | 2005 | 324 |
Why?
| Patient Satisfaction | 4 | 2002 | 120 |
Why?
| Biopsy | 2 | 2006 | 207 |
Why?
| Delayed-Action Preparations | 2 | 2005 | 31 |
Why?
| Antidepressive Agents, Tricyclic | 2 | 2010 | 18 |
Why?
| Double-Blind Method | 11 | 1984 | 274 |
Why?
| Osteoarthritis, Knee | 1 | 2011 | 14 |
Why?
| Vulvodynia | 1 | 2010 | 7 |
Why?
| Depression | 4 | 1986 | 118 |
Why?
| Health Services for the Aged | 1 | 2011 | 29 |
Why?
| Affective Symptoms | 5 | 1994 | 32 |
Why?
| Nerve Fibers | 1 | 2010 | 45 |
Why?
| Questionnaires | 6 | 1996 | 360 |
Why?
| Health Surveys | 1 | 2010 | 103 |
Why?
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2009 | 6 |
Why?
| Internet | 1 | 2010 | 64 |
Why?
| Oxycodone | 1 | 2009 | 8 |
Why?
| Guidelines as Topic | 1 | 2009 | 77 |
Why?
| Vulvar Diseases | 1 | 2009 | 19 |
Why?
| Peripheral Nerves | 2 | 2005 | 26 |
Why?
| Fibromyalgia | 2 | 2005 | 6 |
Why?
| Exanthema | 3 | 1998 | 12 |
Why?
| Analgesics, Non-Narcotic | 2 | 2003 | 21 |
Why?
| Health Expenditures | 1 | 2008 | 27 |
Why?
| Radiotherapy | 2 | 2005 | 73 |
Why?
| Adrenal Cortex Hormones | 1 | 2008 | 76 |
Why?
| Aged, 80 and over | 9 | 1992 | 599 |
Why?
| Multivariate Analysis | 6 | 2001 | 225 |
Why?
| Age Factors | 9 | 1988 | 480 |
Why?
| Bupropion | 1 | 2005 | 2 |
Why?
| Nervous System Diseases | 2 | 2002 | 78 |
Why?
| Surgical Procedures, Operative | 1 | 2006 | 77 |
Why?
| Drugs, Investigational | 1 | 2005 | 8 |
Why?
| Ion Channels | 1 | 2006 | 61 |
Why?
| Carcinoma | 1 | 2006 | 109 |
Why?
| Health Status | 1 | 2007 | 127 |
Why?
| Prospective Studies | 6 | 1992 | 545 |
Why?
| Comorbidity | 4 | 2005 | 190 |
Why?
| Calcium Channels | 1 | 2005 | 52 |
Why?
| Cranial Nerves | 1 | 2003 | 6 |
Why?
| Adolescent | 9 | 1990 | 891 |
Why?
| Pain Insensitivity, Congenital | 1 | 2003 | 1 |
Why?
| Sick Role | 4 | 1986 | 26 |
Why?
| United States | 8 | 1985 | 604 |
Why?
| Young Adult | 3 | 2010 | 380 |
Why?
| Diseases in Twins | 3 | 1988 | 30 |
Why?
| Suicide, Attempted | 1 | 2004 | 42 |
Why?
| Anticonvulsants | 4 | 2005 | 61 |
Why?
| Administration, Topical | 3 | 2004 | 57 |
Why?
| Sex Factors | 6 | 1988 | 284 |
Why?
| Prevalence | 4 | 2000 | 281 |
Why?
| Cohort Studies | 4 | 2005 | 332 |
Why?
| Pain Clinics | 1 | 2000 | 2 |
Why?
| Databases, Factual | 1 | 2001 | 102 |
Why?
| Autonomic Nerve Block | 1 | 2000 | 6 |
Why?
| Chickenpox | 2 | 1996 | 20 |
Why?
| Logistic Models | 4 | 2001 | 251 |
Why?
| Placebos | 4 | 2005 | 110 |
Why?
| Social Adjustment | 5 | 1988 | 38 |
Why?
| Activities of Daily Living | 5 | 1996 | 122 |
Why?
| Stress, Psychological | 4 | 1992 | 117 |
Why?
| Serotonin Uptake Inhibitors | 2 | 2009 | 19 |
Why?
| Antineoplastic Agents | 1 | 2005 | 190 |
Why?
| Retrospective Studies | 4 | 2005 | 653 |
Why?
| Herpes Zoster Vaccine | 2 | 2008 | 3 |
Why?
| European Continental Ancestry Group | 2 | 1996 | 117 |
Why?
| Depressive Disorder | 2 | 1990 | 76 |
Why?
| Psychological Theory | 1 | 1999 | 21 |
Why?
| Herpesvirus 3, Human | 2 | 2007 | 14 |
Why?
| Prognosis | 4 | 1986 | 388 |
Why?
| Workers' Compensation | 2 | 1985 | 6 |
Why?
| Arousal | 2 | 1995 | 37 |
Why?
| Recurrence | 4 | 2000 | 261 |
Why?
| Patient Selection | 2 | 2009 | 155 |
Why?
| Reproducibility of Results | 3 | 1992 | 391 |
Why?
| Psychiatric Status Rating Scales | 6 | 1988 | 99 |
Why?
| Depressive Disorder, Major | 1 | 1999 | 36 |
Why?
| Age Distribution | 3 | 2005 | 127 |
Why?
| Regression Analysis | 4 | 1990 | 256 |
Why?
| Psychomotor Disorders | 1 | 1996 | 18 |
Why?
| Psychology | 2 | 2005 | 31 |
Why?
| Time Factors | 6 | 1990 | 896 |
Why?
| Bipolar Disorder | 1 | 1995 | 35 |
Why?
| Disability Evaluation | 4 | 2006 | 61 |
Why?
| African Americans | 1 | 1996 | 108 |
Why?
| Sensory Receptor Cells | 2 | 2010 | 20 |
Why?
| Mood Disorders | 2 | 1988 | 31 |
Why?
| Animals | 7 | 1996 | 1031 |
Why?
| HIV Infections | 2 | 2010 | 136 |
Why?
| Disease Models, Animal | 2 | 2005 | 349 |
Why?
| Acyclovir | 2 | 1996 | 28 |
Why?
| Psychophysiologic Disorders | 1 | 1992 | 12 |
Why?
| Employment | 3 | 1985 | 47 |
Why?
| Legislation, Drug | 1 | 2011 | 6 |
Why?
| Dose-Response Relationship, Drug | 3 | 2005 | 431 |
Why?
| Transdermal Patch | 1 | 2011 | 3 |
Why?
| High-Frequency Jet Ventilation | 1 | 1990 | 4 |
Why?
| Sleep | 1 | 2011 | 31 |
Why?
| Cross-Sectional Studies | 2 | 2010 | 253 |
Why?
| Pulmonary Ventilation | 1 | 1990 | 16 |
Why?
| Immunocompetence | 2 | 2007 | 15 |
Why?
| Acetaminophen | 1 | 2011 | 17 |
Why?
| Administration, Intravaginal | 1 | 2010 | 10 |
Why?
| Lower Extremity | 1 | 2010 | 15 |
Why?
| Health Services Research | 1 | 2011 | 63 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 141 |
Why?
| Trachea | 1 | 1990 | 50 |
Why?
| Incidence | 3 | 2005 | 336 |
Why?
| Immunocompromised Host | 2 | 2007 | 70 |
Why?
| Anti-Retroviral Agents | 1 | 2010 | 13 |
Why?
| Intubation, Intratracheal | 1 | 1990 | 50 |
Why?
| Analysis of Variance | 4 | 2004 | 339 |
Why?
| Acetamides | 1 | 2010 | 20 |
Why?
| Chi-Square Distribution | 1 | 2011 | 179 |
Why?
| Tramadol | 1 | 2009 | 3 |
Why?
| Analgesia | 1 | 2010 | 27 |
Why?
| Research | 1 | 2011 | 124 |
Why?
| Data Interpretation, Statistical | 2 | 2006 | 109 |
Why?
| Drug Costs | 1 | 2009 | 22 |
Why?
| Databases as Topic | 1 | 2009 | 27 |
Why?
| Cell Count | 1 | 2010 | 163 |
Why?
| Random Allocation | 1 | 2010 | 160 |
Why?
| Longitudinal Studies | 2 | 1991 | 195 |
Why?
| Europe | 1 | 2009 | 54 |
Why?
| Administration, Oral | 1 | 2010 | 170 |
Why?
| Canada | 1 | 2009 | 60 |
Why?
| Prescriptions | 1 | 2009 | 4 |
Why?
| Motor Neurons | 1 | 2010 | 45 |
Why?
| Coitus | 1 | 2009 | 17 |
Why?
| International Cooperation | 1 | 2009 | 42 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2009 | 14 |
Why?
| Texas | 1 | 2009 | 21 |
Why?
| Factor Analysis, Statistical | 1 | 2009 | 45 |
Why?
| Inpatients | 1 | 2009 | 46 |
Why?
| Fatty Acids, Unsaturated | 1 | 2009 | 22 |
Why?
| Drug Synergism | 1 | 2009 | 104 |
Why?
| Drug Combinations | 1 | 2009 | 95 |
Why?
| Drug Administration Schedule | 1 | 2010 | 191 |
Why?
| Culture | 1 | 2009 | 41 |
Why?
| Endpoint Determination | 1 | 2008 | 27 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2009 | 47 |
Why?
| Cross-Over Studies | 2 | 2005 | 82 |
Why?
| Societies, Medical | 1 | 2009 | 90 |
Why?
| Review Literature as Topic | 1 | 2008 | 7 |
Why?
| Diabetes Mellitus | 1 | 2009 | 72 |
Why?
| Sensitivity and Specificity | 2 | 2007 | 427 |
Why?
| Educational Status | 2 | 1986 | 99 |
Why?
| Sample Size | 1 | 2008 | 24 |
Why?
| Adolescent Psychology | 3 | 1990 | 20 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 30 |
Why?
| National Institutes of Health (U.S.) | 1 | 2008 | 45 |
Why?
| Anesthetics | 1 | 2008 | 21 |
Why?
| Medicaid | 1 | 2008 | 48 |
Why?
| Medicare | 1 | 2008 | 48 |
Why?
| Bromodeoxyuridine | 1 | 2007 | 47 |
Why?
| Valine | 1 | 2007 | 27 |
Why?
| Dexamethasone | 1 | 1988 | 109 |
Why?
| Hospitalization | 1 | 2009 | 169 |
Why?
| Insurance, Health | 1 | 2008 | 58 |
Why?
| Health Care Surveys | 1 | 2007 | 91 |
Why?
| Sodium Channel Blockers | 1 | 2006 | 12 |
Why?
| Marital Status | 1 | 2005 | 22 |
Why?
| Causality | 1 | 2005 | 42 |
Why?
| Jurisprudence | 1 | 1985 | 6 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2005 | 13 |
Why?
| Candidiasis, Vulvovaginal | 1 | 2005 | 7 |
Why?
| Capsaicin | 1 | 2005 | 14 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
| Nervous System | 1 | 2005 | 52 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2005 | 23 |
Why?
| Calcium Channel Blockers | 1 | 2006 | 48 |
Why?
| Stroke | 1 | 2008 | 59 |
Why?
| Epidermis | 1 | 2006 | 30 |
Why?
| Weights and Measures | 1 | 2005 | 4 |
Why?
| Treatment Failure | 1 | 2005 | 88 |
Why?
| Leg | 1 | 2006 | 75 |
Why?
| Paclitaxel | 1 | 2005 | 37 |
Why?
| Neural Conduction | 1 | 2006 | 41 |
Why?
| Child | 5 | 1990 | 749 |
Why?
| Linoleic Acids | 1 | 1984 | 7 |
Why?
| Inflammation | 1 | 2009 | 208 |
Why?
| Neurons, Afferent | 1 | 2005 | 48 |
Why?
| Drug Resistance, Viral | 1 | 2005 | 17 |
Why?
| Norepinephrine | 1 | 2005 | 68 |
Why?
| Dosage Forms | 1 | 2004 | 5 |
Why?
| Exercise Movement Techniques | 1 | 2004 | 2 |
Why?
| Zoster Sine Herpete | 1 | 2004 | 1 |
Why?
| Pelvic Pain | 1 | 2005 | 17 |
Why?
| Sex Offenses | 1 | 2005 | 25 |
Why?
| Personality Disorders | 2 | 1988 | 30 |
Why?
| Radiation Injuries | 1 | 2005 | 63 |
Why?
| New York | 1 | 2009 | 422 |
Why?
| Spouse Abuse | 1 | 2005 | 24 |
Why?
| Family Health | 1 | 2004 | 69 |
Why?
| Dopamine | 1 | 2005 | 62 |
Why?
| Adaptation, Psychological | 1 | 2005 | 110 |
Why?
| Mental Disorders | 1 | 1988 | 132 |
Why?
| Social Support | 1 | 2005 | 111 |
Why?
| Sleep Stages | 1 | 2003 | 16 |
Why?
| Dizziness | 1 | 2003 | 10 |
Why?
| Physical Examination | 1 | 2003 | 71 |
Why?
| Lung | 1 | 1990 | 232 |
Why?
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2003 | 2 |
Why?
| Tropical Climate | 1 | 2003 | 1 |
Why?
| Epidemiologic Factors | 1 | 2003 | 3 |
Why?
| Glycine Agents | 1 | 2002 | 4 |
Why?
| Acetic Acids | 1 | 2003 | 31 |
Why?
| Glycine | 1 | 2002 | 40 |
Why?
| Pyrroles | 1 | 2002 | 13 |
Why?
| Asian Continental Ancestry Group | 1 | 2003 | 23 |
Why?
| Safety | 1 | 2003 | 80 |
Why?
| Long-Term Care | 1 | 2003 | 38 |
Why?
| Affect | 1 | 2003 | 55 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2003 | 20 |
Why?
| Trigeminal Nerve | 1 | 2002 | 13 |
Why?
| Interpersonal Relations | 1 | 2004 | 73 |
Why?
| Edema | 1 | 2003 | 67 |
Why?
| Syndrome | 1 | 2002 | 142 |
Why?
| Indoles | 1 | 2002 | 69 |
Why?
| Immune Tolerance | 1 | 2003 | 72 |
Why?
| Follow-Up Studies | 2 | 2004 | 553 |
Why?
| Drug Therapy, Combination | 1 | 2003 | 189 |
Why?
| African Continental Ancestry Group | 1 | 2003 | 80 |
Why?
| Virus Latency | 1 | 2000 | 11 |
Why?
| Virus Activation | 1 | 2000 | 12 |
Why?
| Adrenergic Fibers | 1 | 2000 | 13 |
Why?
| Twins, Monozygotic | 2 | 1988 | 28 |
Why?
| Transcutaneous Electric Nerve Stimulation | 1 | 1999 | 6 |
Why?
| Disease Susceptibility | 1 | 1999 | 61 |
Why?
| Life Change Events | 1 | 1999 | 50 |
Why?
| Rats | 1 | 2005 | 530 |
Why?
| Hypochondriasis | 1 | 1996 | 3 |
Why?
| Facial Expression | 1 | 1996 | 13 |
Why?
| Neurologic Examination | 1 | 1996 | 64 |
Why?
| Age of Onset | 1 | 1996 | 64 |
Why?
| Forecasting | 1 | 1997 | 147 |
Why?
| Thermoreceptors | 1 | 1995 | 1 |
Why?
| Thermosensing | 1 | 1995 | 2 |
Why?
| Skin Temperature | 1 | 1995 | 7 |
Why?
| Discrimination Learning | 1 | 1995 | 20 |
Why?
| Child Psychology | 1 | 1995 | 19 |
Why?
| Self Mutilation | 1 | 1994 | 6 |
Why?
| Tobramycin | 1 | 1993 | 7 |
Why?
| Risk | 1 | 1995 | 203 |
Why?
| Attention | 1 | 1995 | 64 |
Why?
| Case-Control Studies | 2 | 2005 | 283 |
Why?
| Child Development | 1 | 1995 | 49 |
Why?
| Schizophrenia, Catatonic | 1 | 1992 | 1 |
Why?
| Delusions | 1 | 1992 | 5 |
Why?
| Hallucinations | 1 | 1992 | 12 |
Why?
| Personality Development | 1 | 1992 | 11 |
Why?
| Tidal Volume | 1 | 1990 | 24 |
Why?
| Lung Compliance | 1 | 1990 | 26 |
Why?
| Airway Resistance | 1 | 1990 | 15 |
Why?
| Rheology | 1 | 1990 | 28 |
Why?
| Psychometrics | 1 | 1992 | 97 |
Why?
| Surface Properties | 1 | 1990 | 63 |
Why?
| Complex Regional Pain Syndromes | 1 | 2010 | 1 |
Why?
| Bacterial Proteins | 1 | 1993 | 99 |
Why?
| Escherichia coli | 1 | 1993 | 143 |
Why?
| Hepatitis C | 1 | 2010 | 18 |
Why?
| CD4 Lymphocyte Count | 1 | 2010 | 50 |
Why?
| Linear Models | 1 | 2010 | 151 |
Why?
| Equipment Design | 1 | 1990 | 132 |
Why?
| Immunity, Cellular | 1 | 2010 | 85 |
Why?
| Viral Load | 1 | 2010 | 53 |
Why?
| Family | 1 | 1991 | 101 |
Why?
| Child Welfare | 1 | 2010 | 41 |
Why?
| Alcoholism | 1 | 2010 | 51 |
Why?
| Probability Theory | 1 | 2008 | 2 |
Why?
| Infant | 1 | 1995 | 464 |
Why?
| Least-Squares Analysis | 1 | 2008 | 21 |
Why?
| Consensus Development Conferences as Topic | 1 | 2008 | 6 |
Why?
| Confounding Factors (Epidemiology) | 1 | 2008 | 49 |
Why?
| Maryland | 1 | 2008 | 11 |
Why?
| Malingering | 1 | 1988 | 1 |
Why?
| Factitious Disorders | 1 | 1988 | 3 |
Why?
| Education | 1 | 2008 | 28 |
Why?
| Child, Preschool | 1 | 1995 | 554 |
Why?
| Vaccination | 1 | 2010 | 92 |
Why?
| Virus Replication | 1 | 2010 | 90 |
Why?
| Child Health Services | 1 | 2010 | 43 |
Why?
| Somatoform Disorders | 1 | 1988 | 20 |
Why?
| Anxiety Disorders | 1 | 1988 | 31 |
Why?
| Focus Groups | 1 | 2007 | 38 |
Why?
| Mental Health | 1 | 2007 | 43 |
Why?
| Psychological Tests | 1 | 2007 | 60 |
Why?
| Self-Assessment | 1 | 2007 | 35 |
Why?
| Cost of Illness | 1 | 2007 | 54 |
Why?
| Medical History Taking | 1 | 2007 | 53 |
Why?
| Data Display | 1 | 2006 | 15 |
Why?
| Marriage | 1 | 1986 | 22 |
Why?
| Drug Administration Routes | 1 | 2005 | 10 |
Why?
| Injections, Intradermal | 1 | 2005 | 15 |
Why?
| Forearm | 1 | 2005 | 25 |
Why?
| Area Under Curve | 1 | 2005 | 47 |
Why?
| Demography | 1 | 2005 | 87 |
Why?
| Foot | 1 | 2005 | 28 |
Why?
| Nociceptors | 1 | 2005 | 14 |
Why?
| Administration, Cutaneous | 1 | 2005 | 22 |
Why?
| Linoleic Acid | 1 | 1984 | 4 |
Why?
| Models, Biological | 1 | 1990 | 410 |
Why?
| Regional Blood Flow | 1 | 2005 | 105 |
Why?
| Sleep Disorders | 1 | 2005 | 32 |
Why?
| Predictive Value of Tests | 1 | 2006 | 321 |
Why?
| Fatigue | 1 | 2005 | 48 |
Why?
| Probability | 1 | 2005 | 190 |
Why?
| Physician's Practice Patterns | 1 | 2006 | 149 |
Why?
| Reference Values | 1 | 2005 | 278 |
Why?
| Pediatrics | 1 | 2008 | 133 |
Why?
| Blood Pressure | 1 | 2005 | 205 |
Why?
| Emotions | 1 | 2003 | 58 |
Why?
| Heart Rate | 1 | 2005 | 138 |
Why?
| Sensory Thresholds | 1 | 2002 | 25 |
Why?
| Hot Temperature | 1 | 2002 | 93 |
Why?
| beta-Galactosidase | 1 | 1993 | 63 |
Why?
| Enzyme Induction | 1 | 1993 | 64 |
Why?
| RNA, Bacterial | 1 | 1993 | 34 |
Why?
| DNA, Bacterial | 1 | 1993 | 67 |
Why?
| Microbial Sensitivity Tests | 1 | 1993 | 71 |
Why?
|
|
Dworkin's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
